Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Johnson & Johnson shares positive phase 3 results for nipocalimab in myasthenia gravis

The rare autoimmune disease is estimated to affect around 700,000 people globally

- PMLiVE

Study shows epilepsy drug could tackle chemotherapy-resistance in stomach cancer

Clinical trials have been launched to evaluate whether Diacomit causes chemotherapy to work again

Mobile Flexibility – Perks of Virtual Medical Education

Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...

Impetus Digital

- PMLiVE

GSK and CureVac restructure current mRNA collaboration in deal worth over €1.4bn

The companies have been working together to develop mRNA vaccines for infectious diseases since 2020

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by EMA for uncontrolled COPD in adults

Approximately 220,000 COPD patients in the EU could be eligible for Dupixent treatment

- PMLiVE

Johnson & Johnson announces CHMP recommendation for Balversa in bladder cancer

Up to 20% of patients diagnosed with metastatic urothelial carcinoma have FGFR genetic alterations

EU flag

EC approves Valneva’s single-dose chikungunya vaccine for use in adults

The virus has been identified in over 110 countries in Europe, Asia, Africa and the Americas

- PMLiVE

The Importance of LGBTQ Diversity in Healthcare

We take a look at the importance of ensuring diversity in the Pharma industry

Mednet

- PMLiVE

Eli Lilly’s Alzheimer’s drug Kisunla granted FDA approval for early symptomatic disease

The amyloid plaque-targeting therapy could result in lower treatment costs and fewer infusions

regeneron headquarters

Regeneron’s odronextamab recommended by CHMP to treat certain lymphomas

Follicular lymphoma and diffuse large B-cell lymphoma are collectively responsible for an estimated 283,000 global cases every year

- PMLiVE

Merck’s pulmonary arterial hypertension therapy receives CHMP recommendation

Approximately 30,000 people in the EU are currently living with the rare blood disorder

- PMLiVE

Dementia – risk factors, research and treatment

There are over ten million new cases of dementia each year worldwide, which translates into one new case every 3.2 seconds

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links